Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-28 @ 12:16 PM
Study NCT ID:
NCT04999969
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2021-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-03
First Submit QC Date:
None
Study First Post Date:
2021-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-06
Results First Submit QC Date:
None
Results First Post Date:
2025-11-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED